Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis : is the reason to switch relevant?

Detalhes bibliográficos
Autor(a) principal: Manica, Santiago Rodrigues
Data de Publicação: 2020
Outros Autores: Sepriano, Alexandre, Pimentel-Santos, Fernando, Gouveia, Nélia, Barcelos, Anabela, Branco, Jaime C., Bernardes, Miguel, Ferreira, Raquel Miriam, Vieira de Sousa, Elsa Cristina, Barreira, Sofia, Vinagre, Filipe, Roque, Raquel, Santos, Helena, Madeira, Nathalie, Rovisco, João, Daniel, Alexandra, Ramiro, Sofia
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10451/46594
Resumo: © The Author(s). 2020 Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License,which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you giveappropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate ifchanges were made. The images or other third party material in this article are included in the article's Creative Commonslicence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commonslicence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtainpermission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/.The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to thedata made available in this article, unless otherwise stated in a credit line to the data.
id RCAP_b72b1a90396da9fffa4cdd44ec2f5dd8
oai_identifier_str oai:repositorio.ul.pt:10451/46594
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis : is the reason to switch relevant?ASAnkylosing spondylitisSpondyloarthritisSwitchTNFiTreatmentaxSpAbDMARDnr-axSpAr-axSpA© The Author(s). 2020 Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License,which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you giveappropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate ifchanges were made. The images or other third party material in this article are included in the article's Creative Commonslicence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commonslicence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtainpermission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/.The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to thedata made available in this article, unless otherwise stated in a credit line to the data.Background: To investigate whether the reason to discontinue the first TNF inhibitor (TNFi) affects the response to the second TNFi in axial spondyloarthritis (axSpA). Methods: Patients with axSpA from the Rheumatic Diseases Portuguese Register (ReumaPt), who discontinued their first TNFi and started the second TNFi between June 2008 and May 2018, were included. Response was assessed by the Ankylosing Spondylitis Disease Activity Score (ASDAS) clinically important improvement (ASDAS-CII), major important improvement (ASDAS-MI), low disease activity (ASDAS-LDA), and inactive disease (ASDAS-ID). The reason for discontinuation of the first TNFi was defined, according to ASDAS-CII as primary failure (no response ≤ 6 months), secondary failure (response ≤ 6 months but lost thereafter), adverse events, and others. The association between the reason for discontinuation of the first TNFi and response to the second TNFi over time was assessed in multivariable generalized equation (GEE) models. Results: In total, 193 patients were included. The reason for discontinuation of the first TNFi did not influence the response to the second TNFi, according to the ASDAS-CII. However, a difference was found with more stringent outcomes, e.g., there was a higher likelihood to achieve ASDAS-ID with the second TNFi for patients discontinuing the first TNFi due to secondary failure (OR 7.3 [95%CI 1.9; 27.7]), adverse events (OR 9.1 [2.5; 33.3]), or other reasons (OR 7.7 [1.6; 37.9]) compared to primary failure. Conclusion: Patients with axSpA with secondary failure to their first TNFi, compared to those with primary failure, have a better response to the second TNFi according to stringent outcomes.This work was supported by a research grant from Merck Sharp & Dohme Corp., a division of Merck & Co., Inc., Kenilworth, NJ, USA [IIS# 57763]. AS is supported by a doctoral grant from “Fundação para a Ciência e Tecnologia”(SFRH/BD/108246/2015)Springer NatureRepositório da Universidade de LisboaManica, Santiago RodriguesSepriano, AlexandrePimentel-Santos, FernandoGouveia, NéliaBarcelos, AnabelaBranco, Jaime C.Bernardes, MiguelFerreira, Raquel MiriamVieira de Sousa, Elsa CristinaBarreira, SofiaVinagre, FilipeRoque, RaquelSantos, HelenaMadeira, NathalieRovisco, JoãoDaniel, AlexandraRamiro, Sofia2021-03-01T17:38:10Z20202020-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/46594engArthritis Res Ther. 2020 Aug 21;22(1):1951478-635410.1186/s13075-020-02288-81478-6362info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T16:48:59Zoai:repositorio.ul.pt:10451/46594Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:58:44.902295Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis : is the reason to switch relevant?
title Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis : is the reason to switch relevant?
spellingShingle Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis : is the reason to switch relevant?
Manica, Santiago Rodrigues
AS
Ankylosing spondylitis
Spondyloarthritis
Switch
TNFi
Treatment
axSpA
bDMARD
nr-axSpA
r-axSpA
title_short Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis : is the reason to switch relevant?
title_full Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis : is the reason to switch relevant?
title_fullStr Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis : is the reason to switch relevant?
title_full_unstemmed Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis : is the reason to switch relevant?
title_sort Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis : is the reason to switch relevant?
author Manica, Santiago Rodrigues
author_facet Manica, Santiago Rodrigues
Sepriano, Alexandre
Pimentel-Santos, Fernando
Gouveia, Nélia
Barcelos, Anabela
Branco, Jaime C.
Bernardes, Miguel
Ferreira, Raquel Miriam
Vieira de Sousa, Elsa Cristina
Barreira, Sofia
Vinagre, Filipe
Roque, Raquel
Santos, Helena
Madeira, Nathalie
Rovisco, João
Daniel, Alexandra
Ramiro, Sofia
author_role author
author2 Sepriano, Alexandre
Pimentel-Santos, Fernando
Gouveia, Nélia
Barcelos, Anabela
Branco, Jaime C.
Bernardes, Miguel
Ferreira, Raquel Miriam
Vieira de Sousa, Elsa Cristina
Barreira, Sofia
Vinagre, Filipe
Roque, Raquel
Santos, Helena
Madeira, Nathalie
Rovisco, João
Daniel, Alexandra
Ramiro, Sofia
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório da Universidade de Lisboa
dc.contributor.author.fl_str_mv Manica, Santiago Rodrigues
Sepriano, Alexandre
Pimentel-Santos, Fernando
Gouveia, Nélia
Barcelos, Anabela
Branco, Jaime C.
Bernardes, Miguel
Ferreira, Raquel Miriam
Vieira de Sousa, Elsa Cristina
Barreira, Sofia
Vinagre, Filipe
Roque, Raquel
Santos, Helena
Madeira, Nathalie
Rovisco, João
Daniel, Alexandra
Ramiro, Sofia
dc.subject.por.fl_str_mv AS
Ankylosing spondylitis
Spondyloarthritis
Switch
TNFi
Treatment
axSpA
bDMARD
nr-axSpA
r-axSpA
topic AS
Ankylosing spondylitis
Spondyloarthritis
Switch
TNFi
Treatment
axSpA
bDMARD
nr-axSpA
r-axSpA
description © The Author(s). 2020 Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License,which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you giveappropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate ifchanges were made. The images or other third party material in this article are included in the article's Creative Commonslicence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commonslicence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtainpermission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/.The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to thedata made available in this article, unless otherwise stated in a credit line to the data.
publishDate 2020
dc.date.none.fl_str_mv 2020
2020-01-01T00:00:00Z
2021-03-01T17:38:10Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10451/46594
url http://hdl.handle.net/10451/46594
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Arthritis Res Ther. 2020 Aug 21;22(1):195
1478-6354
10.1186/s13075-020-02288-8
1478-6362
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Springer Nature
publisher.none.fl_str_mv Springer Nature
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134533377851392